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Dendritic cells (DCs) regulate both immunity and
tolerance. Here we have shown that the ubiquitin ed-
iting enzyme A20 (Tnfaip3) determines the activation
threshold of DCs, via control of canonical NF-kB acti-
vation. Tnfaip3fl/flCd11c-cre+ mice lacking A20 in
DCs demonstrated spontaneous proliferation of
conventional and double-negative T cells, their
conversion to interferon-g (IFN-g)-producing effector
cells, and expansion of plasma cells. They developed
ds-DNA antibodies, nephritis, the antiphospholipid
syndrome, and lymphosplenomegaly—features of
systemic lupus erythematosus—and extramedullary
hematopoiesis. A20-deficient DCs were resistant to
apoptosis, caused by increased sensitivity to
CD40L and RANKL prosurvival signals and upregula-
tion of antiapoptotic proteins Bcl-2 and Bcl-x. They
captured injected apoptotic cells more efficiently, re-
sisted the inhibitory effects of apoptotic cells, and
induced self-reactive effector lymphocytes. Because
genetic polymorphisms in TNFAIP3 are associated
with human autoimmune disorders, these findings
identify A20-mediated control of DC activation as
a crucial checkpoint in the development of systemic
autoimmunity.
INTRODUCTION
Central tolerance eliminates self-reactive T lymphocytes in the
thymus through negative selection. Self-reactive T cells that
have escaped the thymus can further be deleted or rendered
anergic in the periphery when they recognize their cognate
antigen on resting antigen-presenting cells that reside in the
various lymphoid organs (Mueller, 2010). Autoaggressive CD4+82 Immunity 35, 82–96, July 22, 2011 ª2011 Elsevier Inc.and CD8 T lymphocytes that escape both checkpoints cause
tissue-specific immunopathology. Self-reactive B cells are elim-
inated by central tolerance in the bone marrow (BM), whereas
their maturation into high-affinity plasma cells (PC) in the
periphery is kept in check by the lack of cognate T cell help, nor-
mally provided to B cells by T follicular helper (Tfh) cells that aid in
formation of the germinal center (GC) reaction and somatic
hypermutation. When these checkpoints fail, production of
systemic autoantibodies and immune complex deposition cause
organ pathology because of complement activation and inflam-
matory cell recruitment (Goodnow et al., 2010).
Although DCs are mainly known as the prime inducers of
effector immune responses (Banchereau and Steinman, 1998),
they also play a predominant and essential role in tolerance of
the T cell compartment (Steinman et al., 2003). Internalization
and presentation of self-antigens from apoptotic cells by DCs
are key steps for induction and maintenance of peripheral
T cell tolerance (Kurts et al., 1996). In support, mice in which
conventional DCs (cDCs) are genetically deleted from birth, or
in which cDCs fail to take up apoptotic cells for crosspresenta-
tion, develop signs of severe and systemic autoimmune and
myeloproliferative disease (Birnberg et al., 2008; Ohnmacht
et al., 2009).
It has long been enigmatic howDCs control both immunity and
tolerance. A central understanding is that cDCs that have been
exposed to activating microbial stimuli acting on pattern recog-
nition receptors (PRRs) of the Toll-like receptor (TLR) or nucleo-
tide-binding oligomerization domain (NOD)-like receptor family
(NLR) or cytokines of the tumor necrosis factor receptor
(TNFR) family promote T cell activation through provision of cos-
timulatorymolecules and secretion of polarizing cytokines. In the
absence of these activating stimuli, DCs poorly express costimu-
latory molecules and cytokines and responding T cells are
deleted, rendered anergic, or induced to develop into T regula-
tory cells. Not surprisingly, signaling events downstream of
PRR and cytokine receptors in both DCs and lymphocytes are
closely regulated to allow proper threshold setting and avoid
self-perpetuating activation that could potentially lead to
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A20 in DCs Prevents Autoimmunityautoimmunity (Hanada et al., 2003). Within the TLR, NLR, TNFR,
and interleukin-1 (IL-1) family of receptors, deubiquitination of
signaling intermediates is a key control mechanism that can
terminate overt and prolonged activation of inflammatory
responses (reviewed in Malynn and Ma, 2010). The ubiquitin
editing enzyme A20 (also known as TNF-a-induced protein
[TNFAIP]-3) is a widely expressed and inducible cytoplasmic
protein that negatively regulates NF-kB-driven gene expression
by deubiquitinating several key intermediate NF-kB signaling
molecules like receptor interacting protein-1 (RIP1) and TNF
receptor associated factor 6 (TRAF6) in response to TNFR family,
IL-1R, and TLR signaling (Boone et al., 2004; Wertz et al., 2004).
A20-deficient (Tnfaip3/) mice die prematurely from a severe
wasting disease and show signs of multiorgan inflammation
caused by overzealous reaction to gut microbiota (Lee et al.,
2000). Recently, several single-nucleotide polymorphisms in
the A20 genomic locus were found to be associated with chronic
inflammation and increased susceptibility to various autoim-
mune diseases including systemic lupus erythematosus (SLE),
rheumatoid arthritis, systemic sclerosis, type 1 diabetes,
Crohn’s disease, and multiple sclerosis (Musone et al., 2011).
Given the role of A20 as a suppressor of inflammation, its
genetic linkage to autoimmune diseases, and the crucial role
that DCs play in tolerance mechanisms, we hypothesized that
A20 regulates DC homeostasis and thus prevents autoimmunity.
To determine the cell-intrinsic function of A20, we generated
mice lacking A20 in cells of the DC lineage.
RESULTS
Construction of Mice Lacking A20 Specifically
in CD11c+ DCs
To delete A20 in DCs, C57BL/6 Tnfaip3fl/fl mice (see Figure S1A
available online) were crossed to Cd11c-cremice and intercross
Tnfaip3fl/flCd11c-cre+ (A20-deficient), Tnfaip3fl/flCd11c-cre
(A20-sufficient), Tnfaip3fl/+Cd11c-cre+ (A20 haploinsufficient)
mice were born at normal Mendelian inheritance and developed
to adulthood normally in contrast to Tnfaip3/ mice, which die
prematurely (Lee et al., 2000). Genomic polymerase chain reac-
tion (PCR) analysis of spleen cells of Tnfaip3fl/flCd11c-cre+ and
Cd11c-cre mice demonstrated that CD11c+ major histocom-
patibility class II (MHC-II)+ DCs of cre+ mice deleted the floxed
allele (Figure S1B), and this was supported by Southern blot
analysis on BM-derived CD11c+ DCs (Figure S1C). In some
reports, a subpopulation of T cells displays Cd11c promotor
activity, and indeed there was some deletion of the floxed allele
in T cells on the population level (Figure S1B). Although some
plasmablasts express Cd11c promotor activity, we observed
very few signs of cre-mediated deletion of A20 in splenic B cells
(Figure S1B).
Dendritic Cells Lacking A20 Spontaneously Mature
and Are Hyperresponsive to Activation Stimuli
To determine whether deficiency of A20 affected the develop-
ment of DCs, we grew BM cells of Tnfaip3fl/flCd11c-cre and
cre+mice. Although the efficiency of DC generation was identical
(not shown), the expression of costimulatory molecules like
CD40, CD80, and CD86 were markedly increased in A20-defi-
cient compared with A20-sufficient DCs, suggestive of sponta-neous maturation in the absence of A20 (Figure 1A). The expres-
sion of programmed death ligand-1 (PDL-1) and PDL-2 were
similarly enhanced, although B7 related protein-1 (B7rp-1) was
not altered.
Prior studies have shown that A20 is induced by and restricts
signaling downstream of TLR, NLR, and TNFR family members
on different cell types. Therefore, DCs were exposed to endo-
toxin (a TLR4 agonist), unmethylated bacterial CpG motifs
(a TLR9 agonist), uric acid crystals (UA; a trigger of the NLRP3 in-
flammasome), and TNF-a. Stimulation with all of these induced
maturation in A20-sufficient DCs, read out by upregulation of
CD40 expression (Figure 1B). In the absence of any stimulation,
CD40 expression in A20-deficient DCs was already higher than
in A20-sufficient DCs exposed to lipopolysaccharide (LPS),
CpG, UA, or TNF-a. Further addition of these stimuli therefore
only moderately enhanced CD40 expression in A20-deficient
DCs. Production of proinflammatory cytokines is another aspect
of the functional maturation of DCs. A20-deficient DCs produced
more TNF-a and IL-6 compared with A20-sufficient DCs, both
spontaneously and when triggered with increasing concentra-
tions of TLR agonists, TNF-a, and UA (Figure 1C), whereas pro-
duction of interferon-a (IFN-a) was not detected (data not shown).
Another important checkpoint for DC maturation occurs upon
contact with cognate T cells expressing CD40L after engage-
ment of the T cell receptor (TCR). To model this event, DCs
were exposed to soluble agonistic CD40 antibody (Ab). Addition
of CD40 Ab did not induce expression of costimulatory mole-
cules in A20-sufficient mice and did not further enhance it on
A20-deficient DCs, but, however, markedly increased the
production of IL-6 in DCs lacking A20 (Figure 1D).
To understand how A20 deficiency affects spontaneous and
TLR-driven DC activation, we studied NF-kB and mitogen-acti-
vated protein (MAP) kinase pathways. Consistent with activation
of the canonical NF-kB pathway, the A20-deficient DCs con-
tained more phosporylated inhibitor of NF-kBa (IkBa), indicative
of higher activity of the IkB kinase (IKK) complex in A20-deficient
DCs. Strikingly, phosphorylated IkBawas already found in unsti-
mulated A20-deficient DCs, but not in A20-sufficient DCs,
explaining the spontaneous maturation seen when A20 is lack-
ing. 30 min after stimulation with LPS, phosphorylation of IkBa
was downregulated in A20-sufficient DCs, but not in A20-defi-
cient DCs. There was also persistent phosporylation of JNK,
whereas the activation of p38 MAPK or ERK was not affected
by A20 deficiency in DCs.
Accumulation of DCs and Perturbed Homeostasis
in Tnfaip3fl/flCd11c-cre+ Mice
We next studied the distribution of DCs in the central lymphoid
tissues in vivo. On first examination, 14-week-old
Tnfaip3fl/flCd11c-cre+ mice had massive splenomegaly and
lymphadenopathy, reflected by increased cell counts (Figure 2A).
The thymus had a normal aspect, whereas the BMappeared pale
and hypocellular. The percentage of splenic CD11c+MHC-IIint/+
DCs was increased in cre+ mice, whereas splenic plasmacytoid
DCs (120G8+CD11c+) were decreased (Figure 2B). Splenic
steady-state conventional CD11chi DC subsets can be subdi-
vided by CD4 and CD8a staining. Under conditions of inflam-
mation, an additional CD11bhiSIRP1a+CD11cint monocyte-
derived population can be recruited to the spleen (Naik et al.,Immunity 35, 82–96, July 22, 2011 ª2011 Elsevier Inc. 83
Figure 1. A20-Deficient DCs Are Hypersensitive to Stimuli
(A) Expression of costimulatory molecules on day 9 of GM-CSF-cultured BM-derived DCs derived from Tnfaip3fl/flCd11c-cre (A20-sufficient DCs) or
Tnfaip3fl/flCd11c-cre+ (A20-deficient DCs) mice.
(B and C) BM-DCs were stimulated on day 8 of culture with the indicated stimulus and concentration. On day 9, (B) costimulatory molecules were evaluated via
flow cytometry and (C) cytokine production in the supernatant via ELISA.
(D) BM-DCs were stimulated on day 8 with different concentration of stimulating CD40 Ab and analyzed on day 9.
(E) Immunoblot analysis of phosphorylation of IkBa and MAP kinases in BM-DCs analyzed at various time points after stimulation with 100 ng/ml LPS.
Data are shown as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001. All data shown are representative of at least three independent experiments.
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expressing SIRP1a and CD11b, at the cost of CD8a+ DCs and
CD4+ DCs (Figure 2C). As in vitro, these CD11bhiCD11c+ DCs
have a higher expression of the costimulatory molecules84 Immunity 35, 82–96, July 22, 2011 ª2011 Elsevier Inc.CD40 (and CD86, not shown) compared with cre mice
in vivo (Figure 2D).
Histological analysis revealed that in cre mice, CD11c+ DCs
were found in the CD3+ T cell area and marginal zone of the
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the splenic B cell follicles was nicely delineated by staining for
CD169 expressed by marginal zone macrophages (Figure 2G).
In cre+ mice, splenic follicle anatomy was abnormal and
CD11c+ cells formed intensely dense clusters inside Ter119+
red pulp, making it impossible to discriminate single cells from
multinucleated giant cells, also supported by the fact that they
expressed high levels of the macrophage fusion receptor
SIRP1a (Figure 2H).
Accumulation of DCs in the spleen of Tnfaip3fl/flCd11c-cre+
mice could be due to increased proliferation of cells or pro-
longed survival. To discriminate between these possibilities,
mice received bromodeoxyuridine (BrdU) and spleen cells
were harvested 2 hr later. There was no difference in the degree
of BrdU incorporation in DCs between cre+ and cre mice (Fig-
ure 2I), ruling out differences in proliferation rate. Survival of DCs
is a highly regulated process involving T cell contact via the pro-
survival ligands CD40L and/or RANKL controlling the expres-
sion of the antiapoptotic molecules Bcl-2 and Bcl-x (Josien
et al., 2000). A20 has been shown to control signaling down-
stream of CD40 and RANK, so we tested the sensitivity to their
ligands. Granulocyte macrophage-colony stimulating factor
(GM-CSF)-cultured A20-deficient DCs survived better after
GM-CSF withdrawal (Figure 2J) and under CD40 and RANKL
stimulation. Moreover, they expressed more Bcl-2 and Bcl-x
compared with A20-sufficient DCs, demonstrating that
enhanced survival was the cause for DC accumulation in the
spleen (Figure 2K).
A large part of the increased cellularity of the spleen was
caused by extramedullary hematopoiesis. In cre mice, only
very few Ter119+ cells were nucleated (DAPI+), whereas in
cre+ mice most were indicative of the presence of erythroblasts
(Figures 2E and 2L). In cre+ mice, up to 40% of all splenocytes
were CD71+ erythroblasts, whereas in cre mice these repre-
sented only 5%. In cre+ mice, the serum concentration of the
erythroid growth factor erythropoietin was grossly increased
(Figure 2M). In cre+ mice, there was also an accumulation of
Gr1+CD11b+ myeloid cells to up to 15% of splenocytes,
compared with only 4%–5% in cremice (Figure 2N), and these
cells also accumulated three times the amount of BrdU (data
not shown). The presence of proliferating myeloid cells has
been linked to enhanced expression of the hematopoietic cyto-
kine Flt3L (Birnberg et al., 2008). In cre+, but not cre, mice
there was an increase in the serum Flt3L concentration (Fig-
ure 2O), whereas those of M-CSF and GM-CSF were unaltered
(data not shown).
Tnfaip3fl/flCd11c-cre+ Mice Develop Systemic
Autoimmunity
The spontaneous activation and expansion of DCs found in cre+
mice, together with the massive derangement of splenic archi-
tecture, led us to look for signs of autoimmunity. Whole-body
positron emission tomography imaging after administration of
2,3 Fluorodeoxyglucose demonstrated the presence of wide-
spread inflammation in cre+ mice (Figure 3A), including
increased uptake of the tracer in the spleen and liver. The eryth-
rocyte sedimentation rate, another parameter of systemic
inflammation, was similarly increased in the cre+ mice (Fig-
ure 3B), and the serum concentration of IL-6 (p < 0.05) andTNF-a (p = 0.08), cytokines inducing increased ESR, were
elevated (Figure 3C). In cre+ mice, there were signs of mononu-
clear and PC-rich inflammation in the liver (Figure 3D), heart (Fig-
ure 3E), and pancreas (Figure 3F). However, mice did not
develop diabetes up to 30 weeks of age (not shown). In contrast
to Tnfaip3/ mice, Tnfaip3fl/flCd11c-cre+ mice did not develop
colitis (not shown).
Jones’ staining of kidney sections of 25- to 30-week-old mice
revealedmembranoproliferative glomerulonefritis with increased
glomerular cellularity and thickening of the glomerulocapillary
membranes (Figure 3G). Periodic acid-Schiff (PAS) staining
furthermore revealed increased deposition of extracellular matrix
components in the glomerulus (Figure 3H). The glomeruli of cre+
mice had enhanced deposition of IgG immune complexes (Fig-
ure 3I) accompanied by complement activation and deposition
as revealed by deposition of C3 complement (Figure 3J).
Tnfaip3fl/flCd11c-cre+mice developed severe anemia (Figure 3B)
and had a prolonged bleeding time, caused by thrombocyto-
penia (Figure 3K). 5% to 10% of mice also developed skin
lesions on the ears and arthritis (data not shown). Features of
autoimmunity were seen in both female and male mice and
occurred as early as 10–12weeks of age in somemice. The pres-
ence of antibodies directed against double-stranded (ds) DNA is
a hallmark feature of SLE. In cre+mice aged 12 and 25–30weeks,
we observed an increase in IgG dsDNA antibodies (Figure 3L;
Figure S2A). Screening for more specified autoantibodies by
a panel of absorbed autoantigens revealed the presence of anti-
bodies to ribonucleoprotein in 15% of cre+ mice (Figure S2B).
Female Tnfaip3fl/flCd11c-cre+ mice never gave offspring when
used in breeding, whereas male Tnfaip3fl/flCd11c-cre+ mice
were normally fertile. This was not due to infertility in the female
mice, but resulted from fetal demise; we did observe implanta-
tion embryos at day 4 of gestation (not shown). Recurrent abor-
tion and thrombocytopenia (Figure 3K) are features of the anti-
phospholipid syndrome (APLS). Indeed, cre+ mice had higher
serum concentrations of IgG and IgA cardiolipin antibodies,
typical of the APLs (Figures 3M and 3N).
Increased B Cell Activation Plasma Cell Differentiation
in Tnfaip3fl/flCd11c-cre+ Mice
A break in B cell tolerance to self-antigen is at the heart of
production of aggressive autoantibodies. When a 2 hr pulse
BrdU was given in vivo, B cells of unmanipulated cre+ mice
strongly incorporated BrdU compared with cremice, indicative
of spontaneous B cell activation and proliferation (Figure 4A). In
some models of autoimmunity, high-affinity autoantibodies are
produced by PCs emanating from a Tfh cell-dependent GC reac-
tion (Goodnow et al., 2010), whereas in others they are produced
by more short-lived extrafollicular plasmablasts. Staining for
GL7+B220+Fas+ GC B cells either by flow cytometry (Figure 4B)
or microscopy (Figure 4C) revealed an increased number of GC
B cells in cre+ mice, although we could not find increased
numbers of CXCR5+PD1hiCD4+ Tfh cells in these animals (data
not shown). We next searched for IgG-producing CD138+ PCs.
In the spleens of cre mice, a very low percentage of CD138+
PCs was found in the splenic red pulp (Figure 4D) or by flow
cytometry on total spleen cells (Figure 4E). However, in cre+
mice, there was a strong increase in the number of CD138+
PCs and these cells were strongly positive for IgG1, identifyingImmunity 35, 82–96, July 22, 2011 ª2011 Elsevier Inc. 85
Figure 2. Disturbed Homeostasis of the Lymphohematopoietic System in Tnfaip3fl/flCd11c-cre+ Mice
(A) Cell numbers of spleen, inguinal LN, thymus, and BM.
(B) Analysis of splenic DC populations in 24-week-old mice as shown by staining of CD11c+MHC-II+ (cDCs) and CD11c+120G8+ (pDCs).
(C) Further subset analysis of CD11c+MHC-II+ cells staining for CD4, CD8a, SIRP1a, and CD11b.
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Ter119+ red pulp, where they were very often seen to colocalize
with CD11c+ DCs (Figure 4F).
A20-Deficient DCs Stimulate B Cells Directly
DCs directly stimulate the differentiation, survival, and Ab
production of B cells in the spleen. To study this, CD19+ B cells
were stimulated with DCs in the presence of anti-IgM Fab’ frag-
ments and absence of T cells. When A20-sufficient DCs were
used, B cells proliferated (Figure 5B), yet expressed little of
the B cell activation marker CD38 (Figure 5C) and maintained
high surface expression of IgD and intermediate amounts of
surface IgM (Figure 5D). Meanwhile, when A20-deficient DCs
were used for stimulation of B cells, the B cells proliferated
more vigorously (Figure 5A), they strongly upregulated CD38
(Figure 5B), and they downregulated IgD (Figure 5C). Close to
30% of B cells became IgDIgM whereas some were strongly
surface IgMhiIgD. These findings suggested that A20-deficient
DCs induced the differentiation of antibody-forming cells.
Accordingly, proliferating B cells stimulated with A20-deficient
DCs upregulated the PC marker CD138 (Figure 5D) and on
the mRNA level upregulated the prdm1 mRNA encoding for B
lymphocyte-induced maturation protein-1 (BLIMP-1) (Fig-
ure 5E), a key transcription factor for PC differentiation. Only
in the supernatants of B cells stimulated with A20-deficient
DCs could we detect IgA, IgG1, and IgG2c antibodies indica-
tive of Ig heavy chain class switching (Figure 5F). Because of
the presence of anti-IgM Fab’ fragments in the supernatant,
we could not detect secreted IgM by ELISA, but when we
stained spleens for IgD and IgM, we noticed the occurrence
of IgM+ cells in the red pulp at the expense of IgD+ cells in B
cell follicles in A20-deficient mice (Figure 4G). To better under-
stand how A20-deficient DCs can induce B cell activation and
differentiation in the absence of added T cells, we measured
the mRNA (Figure 5G) or protein (Figure 5H) concentration of
cytokines known to stimulate B cell function and survival, like
IL-21, TGF-b1, BAFF, and APRIL. All of these were increased
in A20-deficient DCs. Whereas BAFF and APRIL have been re-
garded as essential cytokines for promoting B cell survival,
neutralization of both of these by addition of TACI-Fc and
BCMA-Fc (or BAFFR-Fc; data not shown) did not suppress Ig
production induced by A20-deficient DCs (Figure 5I), despite
blocking activity of these compounds on BAFF-induced prolif-
eration (not shown). We had already measured increased IL-6
production in A20-deficient DCs (Figure 1C) because IL-6 is
another B cell growth and differentiation factor. Accordingly,
neutralization of IL-6 reduced IgA production by 50%, indi-(D) Expression of CD40 on CD11c+MHC-II+CD11b+ cells.
(E–H) Immunofluorescent analysis of spleen sections from 24-week-old mice. All
(in green) and CD11c (in red); (F) CD3 (in green), CD11c (in red), and Ter119 (in wh
(in white) and analyzed with confocal microscopy. Scale bars represent 100 mm.
(I) 30-week-old mice were injected with BrdU i.p. and sacrificed 2 hr later. Splee
(J) Day 6 old cultured GM-CSF BM-DCs were deprived of GM-CSF and stimulat
(K) GM-CSF BM-DCs were evaluated for the expression of Bcl-2 and Bcl-x with
(L) Percentage of erythroblast (Ter119+CD71+) in spleens of 25-week-old mice.
(M) Amount of erythropoietin (EPO) determined in serum of 24-week-old mice.
(N) Percentage of myeloid cells (Gr-1+CD11b+) in spleens of 25-week-old mice.
(O) Amount of Flt3L determined in serum of 24-week-old mice.
Data are shown as mean ± SEM; **p < 0.01, ***p < 0.001. All data shown are repcating an important role for IL-6 in mediating increased Ig
production when A20 is lacking in DCs (Figure 5J). However,
neutralization of IL-21 did not affect Ig production by B cells
(data not shown).
Moreover, the in vivo adoptive transfer of A20-deficient DCs
into naive C57BL/6 WT mice led to GC reactions, an expansion
of GC B cells, and accumulation of PCs in the splenic red pulp,
whereas injection of A20-sufficient DCs did not have this effect
(Figure 5K). The injection of A20-deficient DCs furthermore led
to the induction of dsDNA antibodies and IgA anti-cardiolipin
Abs, demonstrating that the effects on autoantibody develop-
ment in Tnfaip3fl/flCd11c-cre+ were intrinsic to DCs (Figures 5L
and 5M).
Increased T Cell Activation and Effector Cell
Differentiation in Tnfaip3fl/flCd11c-cre+ Mice
Because effector T cells and regulatory T cells control autoim-
munity, we studied the thymic and peripheral T cell compart-
ment. The distribution of immature CD4CD8 double-negative
(DN) and CD4+CD8+ double-positive (DP) and mature single-
positive (SP) thymocytes did not reveal differences between
cre+ and cre mice (Figure S3A). Also, there were no defects in
the repertoire of Vb chain TCR usage of cre+ mice, suggesting
normal negative selection (Figure S3B). Without any immuniza-
tion, peripheral splenic CD4+ and CD8+ T lymphocytes incorpo-
rated more BrdU after a 2 hr pulse-chase experiment in vivo,
indicative of enhanced spontaneous T cell activation in cre+
mice (Figure 6A). In support of this observation, the spleens
and LNs of 24-week-old mice contained increased numbers of
activated CD62-LloCD44hiCD4+ (Figure 6B) as well as CD8+ (Fig-
ure 6C) T cells, concomitant with a drop in naive CD4+ and CD8+
T cells. In some autoimmune models (like human autoimmune
lymphoproliferative syndrome [ALPS]), nonconventional T cell
subsets have been found to control autoantibody formation.
One such subset is the CD3+CD4CD8DNpopulation express-
ing the B cell marker B220 in the MRL.lpr mouse. In cre+ mice,
there was a striking increase in the number of these DN cells in
the spleen already at 10 weeks of age (Figure 6D). In murine
models of SLE, increased production of IFN-g has been found
and IFN-g causes several disease manifestations. Accordingly,
in cre+ mice, there was a persistent increase in the percentage
of CD4+ and CD8+ T cells producing IFN-g but not IL-17 in LNs
(not shown) and spleen (Figure 6E). The percentage of B220+
DN T cells producing IFN-g was also strongly increased (Fig-
ure 6F). Loss of natural Treg cells has been found to be a major
cause of autoimmunity in patients andmurinemodels of disease.
When we enumerated the number of Foxp3+CD25hiCD4+ T cellscryosections were counterstained with DAPI and further stained for (E) Ter119
ite); (G) CD169 (in green); and (H) SIRP1a (in green), CD11c (in red), and Ter119
n DCs (CD11c+MHC-II+) were evaluated for BrdU uptake.
ed with CD40 Ab or RANKL. On day 8, survival of DCs was determined.
Q-RT-PCR.
resentative of at least three independent experiments.
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Figure 3. Tnfaip3fl/flCd11c-cre+ Mice Develop Systemic Autoimmunity
(A) Illustration of FDG uptake by PET-CT in a Tnfaip3fl/flCd11c-cre mouse and a Tnfaip3fl/flCd11c-cre+ mouse.
(B) Pictures of citrate-treated blood samples taken from 30-week-old mice to show sedimentation rate of the blood. Pictures of sedimentation were taken at 2
and 4 hr.
(C) IL-6 and TNF-a in serum of 24-week-old mice.
(D–F) H&E staining of liver (D), heart (E), and pancreas (F) of 24-week-old mice. Scale bars represent 100 mm.
(G–J) Jones silverstaining (G), PAS staining (H), and immunofluoresence staining of IgG (I) and complement C3b (J) on paraffin sections of kidneys of 24-week-old
mice. Scale bars represent 20 mm (G and H) or 40 mm (I and J).
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Figure 4. Increased B Cell Activation and Plasma Cell Differentiation in Tnfaip3fl/flCd11c-cre+ Mice
(A) Mice were injected with BrdU intraperitoneally (i.p.) and sacrificed 2 hr later. Spleen B cells (CD19+MHC-II+) were evaluated for BrdU uptake.
(B) Number of germinal center (GC) B cells (GL7+Fas+) in the spleen of 25-week-old mice.
(C) Immunofluorescent staining of GC with GL7 (in green), Ter119 (in red), and follicular dendritic cell (FDC) (in white) staining. Scale bars represent 150 mm.
(D) Immunofluorescent staining of plasma cells with CD138 (in white), Ter119 (in green), and CD11c (in red). Scale bars represent 40 mm.
(E) Number of plasma cells (CD138+B220loCD38+) in the spleen of 25-week-old mice.
(F) Immunofluorescent staining of IgG1+ plasma cells with IgG1 (in red), CD138 (in green), and CD11c (in white).
(G) Staining of plasma cells with IgM (in red), IgD (in green), and CD3 (in white). Scale bars represent 40 mm.
Data are shown as mean ± SEM. All data shown are representative of at least two independent experiments.
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A20 in DCs Prevents Autoimmunityin the LNs and spleen of 8- to 10-week-old Tnfaip3fl/flCd11c-cre+
mice, however, we found no reduction in Treg cells in cre+ mice
(Figure 6G). In older 25- to 30-week-old mice, there was a mark-
edly enhanced percentage of Foxp3+CD25hiCD4+ T cells
(Figure 6H).
A20-Deficient DCs Present Apoptotic Self Antigen
to T Cells Leading to Th1 and Th17 Cell Immunity
Programmed cell death is central to cellular turnover and tissue
homeostasis. As a continuous source of self antigen, apoptotic
cells (ACs) could pose a threat to the organism, if tolerance is
not induced. A20-deficient DCs were more efficient in taking up(K) Platelets were identified in citrate-treated blood as small cells and being CD4
(L–N) Anti-dsDNA-IgG (L), anti-cardiolipin-IgG and IgM (M), and anti-cardiolipin-I
Data are shown as mean ± SEM; *p < 0.05, **p < 0.01. All data shown are represlabeled ACs than A20-sufficient DCs (Figure 7A), whereas the
uptake of soluble protein antigen ovalbumin was identical (Fig-
ure S4A). We also addressed the mRNA for a set of enzymes
and chaperones involved in antigen presentation and found no
gross differences between A20-deficient and -sufficient DCs
(Figure S4B). We next addressed the uptake of ACs by splenic
DCs 2 hr after intravenous (i.v.) injection in vivo. In cre mice,
few CD11c+ cells captured ACs (Figure 7B) and almost no cells
carrying ACs expressed CD11b and SIRP1a. In cre+ mice, more
CD11c+ had captured ACs, and these cells did express CD11b
and SIRP1a. Histological analysis revealed that injected ACs
were taken up by marginal zone CD169+CD11c+ macrophages1+CD45Ter119.
gA (N) concentrations were determined in serum of 28-week-old mice.
entative of at least two independent experiments.
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Figure 5. Direct Activation of B Cells by A20-Deficient DCs
(A) 13 105 A20-sufficient or A20-deficient BM-DCs were cultured with 13 105 CFSE-labeled CD19+ B cells and 10 mg/ml IgM Fab’ fragments. Proliferation was
assessed on day 5 of coculture.
(B–D) Furthermore, the expression of CD38 (B), IgM and IgD (C), and CD138 (D) was determined.
(E) The expression of Blimp-1 mRNA was measured.
(F) In the supernatant of the DC-B cell culture, the amount of IgA, IgG1, and IgG2c were determined by ELISA.
(G) mRNA expression of TGF-b1, BAFF (Tnfsf13b), and APRIL (Tnfsf13) by BM-DCs.
Immunity
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Figure 6. Increased T Cell Activation and Effector Cell Differentiation in Tnfaip3fl/flCd11c-cre+ Mice
(A) Mice were injected with BrdU i.p. and sacrificed 2 hr later. Splenic T cells (CD3+) were evaluated for BrdU uptake.
(B and C) Flow cytometric analysis of naive (CD62L+CD44lo) and effector and memory (CD62LCD44hi) CD4+ T cells (B) and CD8+ T cells (C) in the spleens
of 30-week-old Tnfaip3fl/flCd11c-cre and Tnfaip3fl/flCd11c-cre+ mice.
(D) Number of double-negative (DN) CD3+B220+ T cells in the spleen.
(E and F) Intracellular IFN-g staining was performed and the percentage of IFN-g+ cells of CD4+CD8+ T cells (E) and DN T cells (F) was determined.
(G and H) Evaluation of regulatory T cells (FoxP3+CD25+) in 14-week-old (G) and 30-week-old (H) mice.
Data are shown as mean ± SEM; *p < 0.05, ***p < 0.001. All data shown are representative of at least two independent experiments.
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A20 in DCs Prevents AutoimmunityorDCs incremice (Miyakeet al., 2007),whereas theywere taken
up exclusively by CD11c+CD169 DCs in cre+ mice (Figure 7C).
For studying antigen presentation, we relied on presentation of
the male self antigen HY by female DCs obtained from
Tnfaip3fl/flCd11c-cre+ or -cremice to CD4+ or CD8+ T cells ob-
tained from female HY-antigen-specific TCR transgenic (Tg)
mice. To avoid direct presentation of male antigen by the male
ACs, spleen cells fromMHC-I-deficient (Kd/Kb/) orMhc2/
hosts were rendered apoptotic by UVB treatment and served as
the source of ACs in experiments addressing antigen presenta-
tion to CD8+ or CD4+ T cells, respectively. When female DCs(H) Baseline production of IL-21 by BM-DCs.
(I) IgA production in the supernatant of DC-B cell culture, in which BAFF or APR
(J) IgA production in the supernatant of DC-B cell culture in the presence of a bl
(K) WT C57BL/6 mice were injected with 5 3 106 A20-deficient or -sufficient BM
CD11c (in red), and CD138 (in white) or for GL7 (in green), Ter119 (in red), and B
(L and M) WT C57BL/6 mice injected with 10 3 106 A20-deficient or -sufficien
determined 2 months later.
Data are shown as mean ± SEM; *p < 0.05, ***p < 0.001. All data shown are reprwere pulsed with male MHC-I-deficient ACs, only A20-deficient
DCswere able to induce proliferation in CD8+ HY-TCR Tg T cells,
whereas A20-sufficient were unable to do so (Figure 7D). Anal-
ysis of the supernatants of these cultures demonstrated induc-
tion of Th1 (IFN-g) and Th17 (IL-17) effector cytokine production
in cultures stimulated with A20-deficient DCs, suggestive of the
generation of effector T cell responses inCD8+ T cells (Figure 7E).
Strikingly, the effector cytokines were already made even when
the female DCs were not pulsed with male cells, reflecting the
low threshold for CD8+ T cell activation. Similarly, when
female DCs were pulsed with male MHC-II-deficient ACs, onlyIL were blocked by TACI-Fc or BCMA1-Fc, respectively.
ocking IL-6 antibody.
-DCs on day 0. Spleens were taken at day 6 and stained for MHC-II (in green),
220 (in white). Scale bars represent 30 mm.
t BM-DCs on day 0 and serum dsDNA-IgG (L) and cardiolipin-IgA (M) were
esentative of at least three independent experiments.
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A20 in DCs Prevents AutoimmunityA20-deficient DCs were able to induce proliferation in CD4+
HY-TCR Tg T cells (Figure 7F), and only in these cultures was
there production of effector cytokine IL-17 induced (Figure 7G).
In contrast to the responses in CD8+ T cells, female DCs had to
be pulsed with male ACs to induce effector cytokine production.
To explain the induction of Th cell effector responses, we addi-
tionally measured the production of Th cell instructive cytokines
by DCs. Particularly when exposed to LPS, A20-deficient DCs
produced more IL-12p70, explaining the higher induction of
Th1 cell development (Figure 7H). A20-deficient DCs also
produced extremely high amounts of IL-23 (Figure 7I) and ex-
pressed high amounts of mRNA for TGF-b (Figure 5G), that
together with increased IL-6 and/or IL-1b instruct and enforce
Th17 cell development (Zhou et al., 2007). ACs have been shown
to inhibit the activation of DCs, leading to reduced activation and
antigen presentation (Morelli et al., 2003). We therefore studied
how 2 hr preincubation of DCs with ACs interfered with early
cytokine production induced by the TLR4 agonist LPS (Fig-
ure 7J). In A20-sufficient DCs, prior incubation with ACs inhibited
the LPS-induced production of IL-10, IL-1b, IL-23, and TNF-a,
but not of IL-6 or IL-12p70. Conversely, in A20-deficient DCs,
the production of all these cytokines was strongly increased after
LPS stimulation, and pre-exposure with ACs even increased the
production of several cytokines. Prior studies have shown that
pre-exposure of DCs with ACs inhibits canonical NF-kB activa-
tion and phosphorylation of IkBa in a pathway involving the
Mer tyrosine kinase receptor, triggered by the growth-arrest
specific gene-6 (GAS6) ligand expressed on ACs (Sen et al.,
2007). Pre-exposure of A20-sufficient DCs with ACs or recombi-
nant GAS6 indeed reduced LPS-induced IkBa phosphorylation
15 and 30min after stimulation (Figure 7K). However, in A20-defi-
cient DCs, the pre-exposure to ACs or GAS6 did not reduce IkBa
phosphorylation to the same extent. Therefore, A20 deficiency in
DCs leads to enhanced uptake of ACs, which no longer suppress
canonical NF-kB activation but rather promote persistent DC
activation and development of autoimmunity.
DISCUSSION
By genetically targeting Tnaip3 in CD11c+ cells, we have unrav-
eled a crucial role for A20 and DCs in maintaining immune
homeostasis. Some of the features like dsDNA, ribonucleopro-
tein (RNP), and cardiolipin auto-Abs, membranoproliferative
glomerulonephritis, and thrombocytopenia are features of SLE,Figure 7. Increased Uptake of Apoptotic Cells and Presentation to T C
(A) BM-DCswere exposed to CFSE-labeled apoptotic cells (ACs) at a ratio of 1:4. U
10 mm.
(B and C) 203 106 CFSE-labeled ACwere injected i.v. into Tnfaip3fl/flCd11c-cre
cytometry (B) and confocal analysis (C) on spleen sections stained for CD11c (re
(D and E) Female BM-DCs were exposed to male Kb/Kd/ apoptotic splenocyte
HY-TCR Tg CD8+ T cells. Proliferation was measured on day 4 of culture (D). Cy
(F and G) Female BM-DCs were exposed to male Mhc2/ apoptotic splenocyt
HY-TCR Tg CD4+ T cells. Proliferation was measured on day 4 of coculture (F) a
(H) Production of IL-12p70 by A20-sufficient and A20-deficient BM-DCs after 20
(I) Production of IL-23 by A20-sufficient and A20-deficient BM-DCs after 20 hr L
(J) BM-DCs were incubated with 10 3 106 AC for 2 hr before being pulsed with
(K) Immunoblot analysis of phosphorylated IkBa in BM-DCs. Cells were incubated
LPS.
Data are shown as mean ± SEM; *p < 0.05. All data shown are representative ofwhereas others like the presence of spontaneous lymphocyte
activation, myeloproliferative syndrome, and accumulation of
DN T cells are typically seen in human and murine ALPS. Several
genome-wide association studies have found polymorphisms of
the human TNFAIP3 genomic locus that are associated with SLE
(Musone et al., 2008). A key polymorphism is found in a down-
stream regulatory region of the locus that affects the efficiency
of mRNA transcription (Adrianto et al., 2011). Polymorphisms
at this site affect A20 protein production only mildly, questioning
whether our mouse model of full A20 deficiency in DCs is phys-
iologically relevant. However, many of the autoimmune features
of Tnfaip3fl/flCd11c-cre mice that we have described were also
found in haploinsufficient Tnfaip3fl/+Cd11c-cre+ mice, albeit at
a milder degree compared with full gene-deficient mice (data
not shown).
Recent studies onA20 in autoimmunity have uncovered its role
in regulating B cell activation, with Cd19-cre deleter strains
crossed to mice carrying a different or the same floxed allele of
Tnfaip3 as used here (Chu et al., 2011; Ho¨velmeyer et al., 2011;
Tavares et al., 2010). These mice demonstrate a B cell-intrinsic
hypersensitivity to TLR and CD40L and signs of autoimmunity
like production of autoantibodies and deposition of immune
complexes in thekidneys, butwithout any reportedsignsof organ
damage. These data reinforce the idea that many different path-
waysof activation, some intrinsic toBcell activation andothers at
the levels of DCs or T cells, can lead to B cell autoimmunity.
In contrast to the reported Tnfaip3fl/flCd19-cre mice, the
Tnfaip3fl/flCd11c-cremice hadmore signs of systemic inflamma-
tion reflected by increased sedimentation rates, hypercapitation
on FDG-PET, and increased serum concentrations of TNF-a and
IL-6, also seen in humans with autoimmune diseases.
Several studies have shown that DCs can promote plasma-
blast differentiation at extrafollicular sites and the red pulp (Ba-
la´zs et al., 2002; Garcı´a De Vinuesa et al., 1999). In our model,
we propose that direct B cell activation by A20-deficient DCs
is a major contributing factor for the development of autoanti-
bodies. In support, A20-deficient DCs were excellent at stimu-
lating B cell proliferation and induced the differentiation of
BLIMP1+ class-switched PCs in the absence of any T cell help.
Furthermore, increased numbers of PCs were seen after adop-
tive transfer of A20-deficient DCs to naive wild-type mice.
DC-derived BAFF and APRIL, as well as IL-6 and IL-21, act as
important signals involved in DC-driven B cell interactions
(Mohr et al., 2009; Santiago-Raber et al., 2010). Onlyells by A20-Deficient DCs
ptake of ACwas determined 6 hr later by flow cytometry. Scale bars represent
and Tnfaip3fl/flCd11c-cre+ mice. Uptake of ACs by DCs was determined by flow
d) and CD169 (white). Scale bars represent 50 mm.
s on day 8. On day 9 DCs were placed in coculture with CFSE-labeled female
tokine production in the supernatant was measured (E).
es on day 8. On day 9 DCs were placed in culture with CFSE-labeled female
s well as IL-17 production in the supernatant (G).
hr LPS stimulation.
PS stimulation.
100 ng/ml LPS. 5 hr later, cytokines were determined in the supernatant.
with 103 106 AC or 10 mg/ml GAS6 for 2 hr before stimulation with 100 ng/ml
two independent experiments.
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A20 in DCs Prevents Autoimmunityneutralization of IL-6 reduced the production of class-switched
immunoglobulins driven by A20-deficient DCs. These findings
are in line with previous work showing that IL-6 is a crucial B
cell growth factor that mediates DC-driven differentiation of
plasmablasts (Jego et al., 2003; Mohr et al., 2009).
Multiple signs of activation of the T cell compartment were
also evident in Tnfaip3fl/flCd11c-cre+ mice, like increased spon-
taneous T cell division, conversion to the memory and effector
pool, and increased intracellular amounts of IFN-g. The produc-
tion of IFN-g is increased in patients with SLE, and neutralization
of IFN-g in MRL.lpr mice neutralizes disease severity, demon-
strating that expansion of Th1 cytokine-producing cells is an
important feature of lupus across species and a potential thera-
peutic target (Balomenos et al., 1998). Like in MRL.lpr mice and
patients with ALPS, we also observed an expansion of B220+ DN
T cells in cre+mice and these similarly produced high amounts of
IFN-g. Although we have not studied the functional role of these
cells in our model, these B220+ DN T cells have been shown to
be important in stimulating autoantibody production yet could
also have an immunoregulatory role, by suppressing the activa-
tion of autoreactive T cells (Voelkl et al., 2011).
We observed that with age, there was a progressive increase
in the percentage of Foxp3+ Treg cells in A20-deficient mice.
Nussenzweig and colleagues recently demonstrated the exis-
tence of a feedback regulatory loop between DCs and Treg cells,
driven by the cytokine Flt3L (Liu et al., 2009). Our work and
a recent study in lupus-prone mice show that this close relation-
ship is also true for Treg cell and DC numbers in autoimmunity. In
DC-depleted lupusmice, there is a reduction in Treg cells (Teich-
mann et al., 2010), whereas in our lupus-prone mice with
expanded DCs there was an increase in Treg cell number.
Although the increase in Treg cells induced by DC expansion is
a counterregulatory mechanism, cre+ mice still developed auto-
immunity, possibly because of intrinsic resistance of A20-defi-
cient DCs or induced T effector cells to Treg cell regulation,
a mechanism that was recently proposed (Song et al., 2008).
Our work is an example of development of spontaneous auto-
immunity when DC numbers and their activation is increased.
The SLE susceptibility locus Yaa in mice causes more severe
SLE because of a gene duplication event in a locus carrying
the TLR7 receptor, and these mice as well as Tlr7-BAC trans-
genic mice have increased numbers and activation state of their
DCs (Deane et al., 2007). Conversely, some reports have shown
that constitutive depletion of DCs can also promote autoimmu-
nity and extramedullary hematopoiesis (Birnberg et al., 2008;
Ohnmacht et al., 2009). One likely explanation is that constitutive
deletion of DCs mainly targets the steady-state cDCs that are
deemed important for mediating central and peripheral toler-
ance, thus leading to an abnormal T cell repertoire. In our
Tnfaip3fl/flCd11c-cre+ mice, we mainly observed an expansion
of inflammatory SIRP1a+CD11b+ DCs that also play a predomi-
nant role in disease progression and expansion of memory
effector T cells and autoantibody-producing PCs in spontaneous
lupus models (Teichmann et al., 2010). Inflammatory DCs of
Tnfaip3fl/flCd11c-cre+mice expressedmore costimulatory mole-
cules and made more cytokines and chemokines that can
explain these effects. Particularly in human SLE, several studies
have proposed that plasmacytoid (p)DCs are a crucial source of
IFN-a that can promote activation of monocyte-derived inflam-94 Immunity 35, 82–96, July 22, 2011 ª2011 Elsevier Inc.matory DCs and autoantibody responses when triggered with
immune complexes containing self-DNA (Blanco et al., 2001).
Although at first site we did not find defects in pDCs or type I
IFN production, future studies will have to elucidate the precise
role of this pathway in our model.
Although A20 has antiapoptotic effects in various cell types,
A20-deficient DCs were more resistant to apoptosis and re-
sponded better to DC prosurvival signals expressed on T cells
like CD40L andRANKL. Resistance to apoptosis in A20-deficient
DCs was due to enhanced expression of the antiapoptotic mole-
cules Bcl-2 and Bcl-x, known to control DC survival (Hou and
Van Parijs, 2004) and direct gene targets regulated by NF-kB.
Signaling via CD40 and RANK involves the K63-linked polyubi-
quitination of TRAF6, and A20 was shown to deubiquitinate
K63-polyubiquitin chains of TRAF6 (Boone et al., 2004), explain-
ing increased sensitivity to these ligands in A20-deficient DCs.
Prolonging the survival of DCs through constitutiveCd11c-medi-
ated expression of a caspase inhibitor p35 or through specific
deletion of Fas has been shown to be sufficient to cause autoim-
munity (Chen et al., 2006; Stranges et al., 2007).
ACs are a predominant source of self-antigen for inducing au-
toreactive T and B cells. When exposed to serum of lupus
patients, blood monocytes differentiate into DCs that can
capture and present ACs, the most important source of self anti-
gens, implying that increased capture of ACs by DCs could be
a primary driving force for SLE development (Blanco et al.,
2001). This could explain the reported associations between
reduced clearance of ACs by macrophages (e.g., caused by
deficiencies in complement, reduced expression of ‘‘eat me’’
receptors) and development of autoimmunity, myeloproliferative
syndrome, and SLE (Lu and Lemke, 2001). Notably, we found
that A20-deficient DCs were better at capturing ACs, whereas
normally ACs are cleared by marginal zone CD169+ macro-
phages and/or DCs (Miyake et al., 2007). We noticed that there
was a marked alteration in the localization of these CD169+ cells
in cre+ mice (Figure 2H), so the increased uptake of ACs by DCs
could have been an intrinsic effect of A20 deficiency or have re-
sulted from reduced clearance of ACs by CD169+macrophages.
A20-deficient DCs were also more capable of presenting
AC-derived male self antigen to CD4+ and CD8+ T cells and
induced the generation of IFN-g- and IL-17-producing effector
cells. Blander and Medzhitov (2006) have shown that a crucial
checkpoint in presentation of self-antigen contained in ACs is
the triggering of TLR receptors in the same endosomal compart-
ment containing the ACs. This is why infected ACs can be
a source of self-antigen leading to a break in peripheral self-toler-
ance and development of Th1 and Th17 cell-mediated autoim-
munity (Torchinsky et al., 2009). Our data now show that
a deficiency in the TLR signaling regulator A20 leads to presen-
tation of self-antigen contained in uninfected apoptotic cells.
Whereas pre-exposure to ACs normally suppresses NF-kB acti-
vation and cytokine secretion in DCs through ligation of the eat-
me receptor Mer tyrosine kinase by GAS6 (Lu and Lemke, 2001;
Sen et al., 2007), A20-deficient DCs further increase cytokine
secretion and fail to downregulate upstream NF-kB activation
events when exposed to ACs or recombinant GAS6.
In conjunction with the recent genetic studies that have
consistently found associations between the TNFAIP polymor-
phisms and autoimmunity, our findings put A20-mediated
Immunity
A20 in DCs Prevents Autoimmunitycontrol of DC activation, survival, and apoptotic cell handling as
a crucial checkpoint in tolerance to self.
EXPERIMENTAL PROCEDURES
Mice
Tnfaipfl/flmice (Vereecke et al., 2010)were crossedwithCd11c-cremice (Caton
et al., 2007). Female MHC-I-restricted H-Y TCR Tg mice were from Taconic
Farms (France) and female MHC-II-restricted H-Y TCR Tg Rag1/ mice
were provided by L.-M. Charbonnier (Free University Brussels). Male KdKb/
and male Mhc2/ were provided by G. Leclercq (Ghent University). Experi-
ments were performed on mice backcrossed into the C57BL/6 genetic back-
ground for at least five generations and housed under SPF conditions. Mice
were analyzed at 24–30weeks of age, unless otherwise stated. All experiments
were performed under approval by the animal ethics committee of Ghent
University.
Generation of BM-Derived DCs
To obtain inflammatory DCs, BM cells were cultured for 9 days in culture
medium containing 20 ng/ml of GM-CSF, as previously described. Different
stimuli were added 18 hr prior to harvesting the cells.
For DC survival assays, BM-DCs were harvested on day 6 of culture. They
were replated in 24-well plates at 1 3 106 cells/ml, 1 ml per well with low
dose of GM-CSF (2 ng/ml) or no GM-CSF. Different concentrations of stimu-
lating CD40 Ab (clone FGK-45) or RANKL (R&D Systems) was added to the
DCs. On day 8, cells were harvested and counted for survival via flow
cytometry.
Pulsing with Apoptotic Cells
Apoptosis was induced in splenocytes by UV crosslinking (200 mJ/cm2). After
1 hr at 37C, 70% of the cells were in early apoptotic (Annexin V+ 7AAD) and
10% late apoptotic and necrotic (Annexin V+ 7AAD+) stage. BM-DCs were
exposed to AC (ratio of approximately 1 DC:4 AC) or recombinant GAS6
(10 mg/ml, R&D Systems). For uptake of AC in vivo or in vitro, splenocytes
were labeled with 2 mM carboxy fluorescein diacetate succinimidyl ester
(CFSE) before apoptosis induction. In vivo, mice were sacrificed 2 hr after
i.v. injection of AC. In vitro uptake of ACwas determined at 6 hr postincubation.
Antigen Presentation of Apoptotic Cells
HY-specific TCR TgCD8+ T cells or CD4+ T cells were isolated from spleen and
lymph nodes by negative selection with MACS (Miltenyi Biotec) and labeled
with CFSE (Invitrogen). 23 104 pulsed or unpulsed female DCs were cultured
with 23 105 CD8+ or CD4+ T cells. After 4 days, cells were harvested and HY-
specific T cell proliferationwas determined by staining CFSE-labeled cells with
CD4-PE-Texas Red, CD3-PE-Cy5, CD44-AF700, and CD8a-eFluor450.
Coculture of B Cells and DCs
BM-derived inflammatory DCswere collected on day 9 and placed in coculture
with purified splenic B cells fromC57BL/6mice. B cells were positively isolated
with CD19+ beads (Miltenyi). Depending on the experiment, B cells were
labeled with 1 mM CFSE or not. 105 DCs were placed in coculture with 1 3
105 B cells and 10 mg/ml IgM Fab’ fragments (Jackson Immunoresearch). In
experiments to evaluate the influence of BAFF, APRIL, and IL-6, blocking
Fc-reagents were added (10 mg/ml TACI-Fc, BCMA-Fc, or control human IgG;
R&D Systems) or 10 mg/ml IL-6 Ab or control rat IgG (eBioscience) was used.
Statistical Analysis
For all experiments, the difference between groups was calculated with the
Mann-Whitney U test for unpaired data (GraphPad Prism version 4.0; Graph-
Pad, San Diego, CA). Differences were considered significant when p < 0.05 (*),
p < 0.01 (**), or p < 0.005 (***).
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